GENE ONLINE|News &
Opinion
Blog

Deals
Jounce Sells Anti-CCR8 Antibody to Gilead, Forgoing $645 Million In Milestones
2022-12-28
Antengene To Pair CD73 Inhibitor With Merck’s Keytruda In Clinical Collaboration
2022-12-27
Pfizer Begins Phase 2 Of Diabetes Drug, Triggering $10 Million Milestone To Sosei Heptares
2022-12-22
Jazz Opts Into License Zymeworks’ Solid Tumor Med With $325 Million Payment
2022-12-21
Kite Buys Tmunity To Chase Next-Generation CAR T-Cell Therapies
2022-12-21
Prenetics Announces Acquisition of ACT Genomics, Aiming for the Multi-billion Market of Precision Oncology
2022-12-21
Biogen To Receive Potential Royalties For Anti-CD20 Bispecific From Genentech
2022-12-20
LG Chem Lands Innovent As China Partner For Gout Candidate
2022-12-15
GSK Buys into Wave’s Oligonucleotide Program With $170 Million
2022-12-14
Vallon and GRI Bio Strike a Merger Deal, Joining Forces for Innovative NKT Cell Regulators
2022-12-14
Clovis Offloads Cancer Candidate to Novartis, Day After Declaring Bankruptcy
2022-12-13
Kite And Arcellx Join Forces for Developing Cell Therapy targeting Multiple Myeloma
2022-12-12
Amgen Leads the Pack After Sanofi Drops Out of Horizon Bid
2022-12-11
Summit Bets $5 Billion On Akeso’s Bispecific Antibody
2022-12-07
European Commission Continues Fight with Illumina and Orders Grail Acquisition Divestment
2022-12-07
1 2 3 4 5 39
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top